ArticleBMJ supportive & palliative care2017
Preferred and actual place of death in haematological malignancy.
Article in BMJ supportive & palliative care, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- A modelled cost-utility analysis comparing early referral to specialist palliative care versus standard care for older people with acute myeloid leukaemia.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025Pooled it
- Levels and Determinants of Place-Of-Death Congruence in Palliative Patients: A Systematic Review.Frontiers in psychology · 2021Pooled it
- Preferred Place of Death in Adult Cancer Patients: A Systematic Review and Meta-Analysis.Frontiers in psychology · 2021Pooled it
- The impact of nursing care and difficulties training given to nurses on dying cancer patient on quality of care and difficulties: a randomized controlled study.BMC nursing · 2026Article
- Prognostic discussions in patients with advanced lymphoma: Characteristics and challenges.Palliative & supportive care · 2025Article
- Caregivers influence preferred place of death for patients with an advanced cancer.Palliative & supportive care · 2025Article
- Research Strategy for the Development of a Quality-of-Life Decision-Making Model for Older Patients With Acute Myeloid Leukemia.Journal of the advanced practitioner in oncology · 2023Article
- Palliative Care in Patients with Hematological Malignancies.Florence Nightingale journal of nursing · 2023Article
- Variation in hospital cost trajectories at the end of life by age, multimorbidity and cancer type.International journal of population data science · 2023Article
- Intensity of care in cancer patients in the last year of life: a retrospective data linkage study.British journal of cancer · 2022Article
- Symptom Prevalence and Place of Death Preference in Advanced Cancer Patients: Factors Associated With the Achievement of Home Death.The American journal of hospice & palliative care · 2022Article
- The functional roles of the circRNA/Wnt axis in cancer.Molecular cancer · 2022Review
- The quality of end of life care for Danish cancer patients who have received specialized palliative: a national survey using the Danish version of VOICES-SF.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022Article
- Preferred and actual place of death in haematological malignancies: a report from the UK haematological malignancy research network.BMJ supportive & palliative care · 2021Article
- Where Do Cancer Patients in Receipt of Home-Based Palliative Care Prefer to Die and What Are the Determinants of a Preference for a Home Death?International journal of environmental research and public health · 2020Article
- End-of-life care quality outcomes among Medicare beneficiaries with hematologic malignancies.Blood advances · 2020Article
- Illness Understanding and Advance Care Planning in Patients with Advanced Lymphoma.Journal of palliative medicine · 2020Observational
- The Quality of End-of-Life Care among ICU versus Ward Decedents.American journal of respiratory and critical care medicine · 2020Article
- Palliative and End-of-Life Care for Patients With Hematologic Malignancies.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020Review
- Variations in Physician Orders for Life-Sustaining Treatment Program across the Nation: Environmental Scan.Journal of palliative medicine · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectivesHome is considered the preferred place of death for many, but patients with haematological malignancies (leukaemias, lymphomas and myeloma) die in hospital more often than those with other cancers and the reasons for this are not wholly understood. We examined preferred and actual place of death among people with these diseases.
methodsThe study is embedded within an established population-based cohort of patients with haematological malignancies. All patients diagnosed at two of the largest hospitals in the study area between May 2005 and April 2008 with acute myeloid leukaemia, diffuse large B-cell lymphoma or myeloma, who died before May 2010 were included. Data were obtained from medical records and routine linkage to national death records.
results323 deceased patients were included. A total of 142 (44%) had discussed their preferred place of death; 45.8% wanted to die at home, 28.2% in hospital, 16.9% in a hospice, 5.6% in a nursing home and 3.5% were undecided; 63.4% of these died in their preferred place. Compared to patients with evidence of a discussion, those without were twice as likely to have died within a month of diagnosis (14.8% vs 29.8%). Overall, 240 patients died in hospital; those without a discussion were significantly more likely to die in hospital than those who had (p≤0.0001). Of those dying in hospital, 90% and 75.8% received haematology clinical input in the 30 and 7 days before death, respectively, and 40.8% died in haematology areas.
conclusionsMany patients discussed their preferred place of death, but a substantial proportion did not and hospital deaths were common in this latter group. There is scope to improve practice, particularly among those dying soon after diagnosis. We found evidence that some people opted to die in hospital; the extent to which this compares with other cancers is of interest.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.